Skip to main content
RUBICON RESEARCH LIMITED logo

RUBICON RESEARCH LIMITED — Investor Relations & Filings

Ticker · RUBICON ISIN · INE506V01022 LEI · 335800GME6PCQIKP8T34 BSE.NS Manufacturing
Open in API
Filings indexed 118 across all filing types
Latest filing 2025-11-07 Proxy Solicitation & In…
Country IN India
Listing BSE.NS RUBICON

About RUBICON RESEARCH LIMITED

https://www.rubicon.co.in/

Rubicon Research Limited is a specialty organization focused on formulation development and the commercialization of value-added products. The company leverages proprietary drug delivery technology platforms to develop complex oral solids, liquids, topicals, and sterile dosage forms. Its core business activities encompass contract research and manufacturing services alongside the development of a diverse portfolio of Abbreviated New Drug Applications. The firm operates advanced research and development centers and manufacturing facilities that comply with stringent international regulatory standards. Rubicon Research emphasizes innovation in life cycle management and the enhancement of existing molecules to improve patient compliance and therapeutic outcomes. Its operations provide end-to-end solutions from initial concept and formulation design to commercial-scale production, serving global markets with a focus on high-quality, technology-driven solutions.

Recent filings

Filing Released Lang Actions
Notice of Postal Ballot
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice of a Postal Ballot issued by Rubicon Research Limited, dated November 7, 2025. It includes information about the resolutions to be voted on, the e-voting schedule, and compliance with SEBI Listing Regulations and the Companies Act, 2013. The content focuses on informing shareholders about the voting process and the proposed resolutions, including approval of agreements and ratification of stock option plans. There are no financial statements, earnings data, or management discussion of financial results. The document is not a report but a formal notice to shareholders to solicit votes via postal ballot. This fits the definition of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings or resolutions.
2025-11-07 English
Shareholders meeting
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice of a Postal Ballot issued by Rubicon Research Limited, dated November 7, 2025. It includes information about the proposed resolutions to be voted on by shareholders via remote e-voting, the schedule for voting, and the nature of the resolutions (ordinary and special). The document references compliance with the Companies Act, 2013, SEBI Listing Regulations, and other regulatory provisions. It is clearly a notice sent to shareholders to inform them about the postal ballot process and the resolutions to be considered, rather than the results of the vote or a report on the meeting outcomes. The document is not a full Annual Report, Earnings Release, or Management Discussion and Analysis. It is not a proxy solicitation or voting results announcement but a notice to shareholders to solicit their votes. Therefore, the document fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings or ballots.
2025-11-07 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-11-07 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 90% confidence The document is a formal announcement addressed to stock exchanges about an upcoming earnings conference call scheduled for November 13, 2025, to discuss the company's financial performance for the quarter and half year ended September 30, 2025. It includes details such as the date, time, participants, and dial-in information for the call. The document does not contain actual financial statements or detailed financial analysis but serves as an invitation and notification of the earnings call event. Therefore, it is classified as a Call Transcript (CT) type document, specifically an announcement of the earnings conference call rather than the transcript itself. However, since the document is an announcement of the call and not the transcript, the best fitting category is Call Transcript (CT) as per the definitions provided, which includes full text transcripts of company conference calls or related announcements about such calls.
2025-11-07 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the schedule of Earnings ....
Call Transcript Classification · 85% confidence The document is a formal announcement addressed to stock exchanges regarding the schedule of an earnings conference call to discuss the company's financial performance for the quarter and half year ended 30th September 2025. It includes details about the call date, time, participants, and dial-in information. The document does not contain actual financial statements or detailed financial analysis but serves to inform about the upcoming earnings call event. The document length is 3246 characters, which is relatively short and consistent with an announcement rather than a full report or transcript. Therefore, this document is best classified as a Call Transcript announcement (CT) or an announcement of an earnings call. However, since it is only an invitation and schedule notice, not the transcript itself, the best fitting category is Regulatory Filings (RNS) as a general announcement about the earnings call. But given the options, the closest specific category is Call Transcript (CT) because it relates directly to the earnings call event. Confidence is high due to clear mention of earnings call schedule and participants, but no transcript text is present, so confidence is moderate to high.
2025-11-07 English
Rubicon Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve Intimation for Meeting of ....
Regulatory Filings Classification · 95% confidence The document is a formal notice addressed to stock exchanges (BSE and NSE) informing about an upcoming Board Meeting scheduled for 13th November 2025. The purpose of the meeting is to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended 30th September 2025. The document references Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements), 2015, which pertains to disclosure of events or information by listed entities. The document is short (2399 characters) and serves as an intimation or announcement of a board meeting rather than containing any financial results or detailed report itself. It does not contain actual financial data or detailed analysis, nor is it a certification or voting result. Therefore, it is best classified as a Regulatory Filing (RNS), which is the fallback category for such regulatory announcements that do not fit other specific categories.
2025-11-07 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.